R-alpha lipoate de sodium in food supplements
122 supplements declared in France contain R-alpha lipoate de sodium as a substance or active ingredient.
Other names in the Compl'Alim list: Na-RALA, Sodium R-lipoate.
Compl'Alim declarations. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
In plain words
À quoi il sert, selon les fabricants
Objectifs les plus souvent annoncés pour les compléments qui en contiennent (R-alpha lipoate de sodium) : antioxydant (22 produits), immunité (7 produits), détoxifiant / draineur (5 produits), digestion (3 produits), circulation sanguine et lymphatique (2 produits).
Ce sont les objectifs déclarés par les fabricants à l'administration, pas des effets démontrés. Sur l'emballage, seules les allégations de santé autorisées par l'Union peuvent être écrites.
Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
What the registers say, country by country
Each line repeats what an official register says on the date it was consulted. Not being in a register means neither allowed nor banned.
Compl'Alim ingredient list (France): listed.
Compl'Alim, reference list of ingredients, retrieved 21 October 2026.
United States, supplement labels (DSLD; supplements need no prior approval): 24 products.
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Official warnings (Health Canada)
DL-ALPHA-LIPOIC ACID/R-ALPHA-LIPOIC ACID
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Jacob et al. 1999, Konrad et al. 1999, Packer et al. 1995).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 42 milligrams or more DL-alpha-lipoic acid or 21 milligrams or more R-alpha-lipoic acid, per day.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience sweating, paleness, chills, headache, dizziness and/or confusion (as these may be symptoms of serious low blood sugar) (Bae et al., 2013; Gullo et al., 2014; Bresciani et al., 2011; Chang et al., 2009).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Texts from the monograph of Health Canada, the Canadian authority, reproduced without modification. They do not replace medical advice.
Products
- Mitochondryn gélule, declared in 2018
- Multi Essentiel Active Plus gélule, declared in 2025
- NA-R-ALA LIFE PRO, gélule, declared in 2025
- NA-R-ALA LIFE PRO, capsule, declared in 2023
- NA-R-ALA LIFE PRO ESSENTIALS, capsule, declared in 2018
- NEUROPLASTINE + Lisarce, gélule, declared in 2026
- NUCLEI QUANTUM SULFUR gélule, declared in 2026
- NUTRAEXPERT LIPO HCA comprimé, declared in 2017
- NUTRAEXPERT PROTECT M comprimé, declared in 2017
- NaRALA gélule, declared in 2018
- NaRALA+ gélule, declared in 2019
- Neuro-Nutrition Formula gélule, declared in 2024
- Neuroplastine Bivea, gélule, declared in 2019
- Nutri-R-Lipoate comprimé, declared in 2018
- NutriDetox comprimé, declared in 2018
- Nutrimonium HMO poudre, flavour pêche-mangue, declared in 2021
- Nutrimonium fodmap free poudre, declared in 2018
- Nutrimonium original poudre, declared in 2018
- OPTICOMPLEXE VIT'ALL +, gélule, declared in 2023
- ORO-TOR gélule, declared in 2022
- OptiVision SuperSmart, gélule, declared in 2024
- Protectum + LORICA, gélule, declared in 2020
- Quicksilver Scientific, Clear Way Cofactors Quicksilver Scientific, gélule, declared in 2026
- R lipoic 260 gélule, declared in 2017
- R-ALPHA-LIPOÏQUE gélule, declared in 2023
- R-Alpha Liponsäure Vitamaze, capsule, declared in 2020
- R-Alpha-Lipoate La Royale, gélule, declared in 2024
- R-LIPOATE DE SODIUM SANTEREL, gélule, declared in 2024
- R-Lipoïc Acide Sodium Salt 300mg gélule, declared in 2020
- R-alpha Lipoate de Sodium liposomal Nutrixeal, gélule, declared in 2025
- R-alpha lipoate de sodium 100 mg Nutrixeal, gélule, flavour néant, declared in 2016
- R-alpha lipoate de sodium 375 mg Nutrixeal, gélule, declared in 2019
- R-lipoate de Sodium DYNVEO, gélule, declared on 6 January 2020, declaration 299694
- R-lipoate de Sodium DYNVEO, gélule, declared on 6 January 2020, declaration 299693
- Redux AK Factors origen pure, gélule, declared in 2019
- Sodium R Lipoate Laboratoire Beauchamp, gélule, declared on 21 June 2018
- Sodium R Lipoate Laboratoire Beauchamp, gélule, declared on 12 February 2018
- Sodium R Lipoate LE PRE VERT, gélule, declared in 2020
- Sodium R Lipoate 400 mg natureforme, gélule, declared in 2022
- Sodium R-Lipoate comprimé, declared in 2023
- Stabilized R-Lipoic Acid Doctor's Best, capsule, declared in 2024
- Super R-Lipoic Acid gélule, declared in 2023
- Super R-Lipoic Acid 240mg Life Extension, capsule, declared in 2023
- UltraDyn Agrumes poudre, declared in 2018
- UltraDyn Natural 3.0 poudre, declared in 2024
- UltraDyn Natural 3.0 poudre, declared in 2018
- UltraDyn fodmap free poudre, declared in 2019
- UltraDyn® poudre, declared in 2025
- UltraDyn® Fodmap Free poudre, flavour goût tropical, declared in 2025
- UltraDyn® Natuur sachet sachet, declared in 2025
- proenage Atox origen pure, gélule, declared in 2018
- pump universal nutrition, gélule, flavour neutre, declared in 2025
- sodium R lipoate gélule, declared in 2017
- ACIDE R ALPHA LIPOIQUE SOFINNOV, comprimé, withdrawn from the market
- Acide R alpha lipoique gélule, earlier declaration, replaced by the 2024 declaration
- Acide R-ALA Bio-Enhanced® capsule, earlier declaration, replaced by the 2019 declaration
- Activ-Hépato Lorica, gélule, earlier declaration, replaced by the 2026 declaration
- EQUILIBRE GLYCEMIQUE comprimé, earlier declaration, replaced by the 2020 declaration
- EQUILIBRE R ALPHA- LIPOIQUE gélule, withdrawn from the market
- Hépatique Lorica, gélule, withdrawn from the market